MedPath

Meperidine

Generic Name
Meperidine
Brand Names
Demerol
Drug Type
Small Molecule
Chemical Formula
C15H21NO2
CAS Number
57-42-1
Unique Ingredient Identifier
9E338QE28F

Overview

A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.

Background

A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration.

Indication

Used to control moderate to severe pain.

Associated Conditions

  • Severe Pain

FDA Approved Products

MEPERIDINE HYDROCHLORIDE
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength:50 mg in 1 mL
Approved: 2024/01/30
NDC:0641-6053
DEMEROL
Manufacturer:Hospira, Inc.
Route:INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength:25 mg in 1 mL
Approved: 2024/04/02
NDC:0409-1362
DEMEROL
Manufacturer:Hospira, Inc.
Route:INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength:50 mg in 1 mL
Approved: 2024/04/02
NDC:0409-1178
MEPERIDINE HYDROCHLORIDE
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength:25 mg in 1 mL
Approved: 2024/01/30
NDC:0641-6052
Meperidine Hydrochloride
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2012/03/06
NDC:54868-1233

Singapore Approved Products

Pethidine-hameln Solution for Injection 50mg/ml
Manufacturer:Siegfried Hameln GmbH
Form:INJECTION, SOLUTION
Strength:50mg
Online:Yes
Approved: 2014/11/14
Approval:SIN14662P
DBL PETHIDINE HYDROCHLORIDE INJECTION BP 50mg/ml
Manufacturer:Siegfried Hameln GmbH
Form:INJECTION
Strength:50 mg/ml
Online:Yes
Approved: 1988/05/04
Approval:SIN00753P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath